Nuvation bio inc. (NUVB-WT) 2025Q4 financial report shows revenue of 41.87M USD, with a YoY growth rate of 633.06%. This outstanding figure clearly proves the company’s exceptionally strong operational momentum and significant expansion in market demand. To accurately capture Nuvation bio inc. (NUVB-WT)’s future growth potential, investors should closely follow subsequent financial reports and key strategic movements, and deeply integrate diversified data and tools such as Growin AI Value Analysis for a comprehensive and forward-looking strategic assessment.